Tempest Therapeutics Inc (TPST) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Tempest Therapeutics Inc   (NASDAQ: TPST)

Tempest Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information




TPST Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 70.86 % 67.38 % 46.15 %
Gross Margin (Q2 TTM) - 71.39 % 67.8 % 46.36 %
Gross Profit Margin 5 Yr. Avg. - 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) - 21.18 % 18.45 % 20.46 %
EBITDA Margin (Q2 TTM) - 25.13 % 20.78 % 20.1 %
EBITDA Margin 5 Yr. Avg. - 47.09 % 31.38 % 23.39 %
Operating Margin (Q2 MRQ) - 17.04 % 16.52 % 16.05 %
Operating Margin (Q2 TTM) - 20.45 % 17.83 % 16.34 %
Operating Margin 5 Yr. Avg. - 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) - 13.42 % 10.72 % 13.96 %
Pre-Tax Profit Margin (Q2 TTM) - 16.68 % 12.68 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.98 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) - 9.91 % 8.02 % 11.42 %
Net Margin (Q2 TTM) - 13.16 % 9.86 % 10.76 %
Net Margin 5 Yr. Avg. - 5.79 % 6.08 % 10.8 %